Consentini Carlos E C, Carneiro Tiago O, Neri Humberto, Batista Emiliana O S, E Silva Lucas O, Souza Alexandre H, Sartori Roberto
Department of Animal Science, University of São Paulo, Piracicaba, SP, Brazil, 13418-900.
Bela Vista Farm, Tapiratiba, SP, Brazil, 13760-000.
JDS Commun. 2022 Mar 31;3(3):212-216. doi: 10.3168/jdsc.2022-0212. eCollection 2022 May.
The present study evaluated the addition of gonadotropin-releasing hormone (GnRH) concomitant or 2 d after the beginning of protocols initiated with estradiol benzoate (EB). A total of 459 multiparous and 371 primiparous lactating Holstein cows were enrolled in the study. Weekly cohorts of cows were randomly assigned to 1 of 3 experimental groups that differed in the strategy to initiate the timed AI (TAI protocol. On d 0, all cows received a 1.55-g progesterone (P4) implant. Additionally, cows in the EBd0 group received 2 mg of EB i.m.; cows in the EBd0-GnRHd0 group were treated simultaneously on d 0 with 2 mg of EB plus 100 µg of gonadorelin diacetate tetrahydrate (GnRH) i.m.; and cows in the EBd0-GnRHd2 group received 2 mg of EB on d 0 and 100 µg of GnRH 48 h later (d 2). The remaining treatments in the protocol were similar among groups and included 0.53 mg (i.m.) of cloprostenol sodium (PGF) on d 7, followed by a second PGF treatment on d 9 (at the time of P4 implant withdrawal) and 1 mg of estradiol cypionate i.m. Then, TAI was performed on d 11 (48 h after P4 removal) in all experimental groups. We detected an effect of treatment on pregnancy per AI (P/AI) on d 30, in which cows from the EBd0-GnRHd2 group demonstrated greater fertility than EBd0 cows, whereas cows in the EBd0-GnRHd0 group did not differ among EBd0 and EBd0-GnRHd0 (40.5 vs. 30.4 vs. 34.4%, respectively). In summary, GnRH treatment at the beginning of an estradiol and P4-based TAI protocol increased fertility only when GnRH was given on d 2. Moreover, a more pronounced positive effect of this strategy was observed in particular classes of cows: multiparous cows, cows with greater milk production, and those receiving the first service.
本研究评估了在以苯甲酸雌二醇(EB)启动的方案开始时或开始后2天添加促性腺激素释放激素(GnRH)的效果。共有459头经产和371头初产泌乳荷斯坦奶牛参与了本研究。每周将奶牛群组随机分配到3个实验组中的1个,这3个实验组在启动定时人工授精(TAI方案)的策略上有所不同。在第0天,所有奶牛都植入了1.55克孕酮(P4)。此外,EBd0组的奶牛肌肉注射2毫克EB;EBd0 - GnRHd0组的奶牛在第0天同时接受2毫克EB加100微克醋酸二水合戈那瑞林(GnRH)的肌肉注射;EBd0 - GnRHd2组的奶牛在第0天接受2毫克EB,并在48小时后(第2天)接受100微克GnRH。方案中的其余处理在各组之间相似,包括在第7天肌肉注射0.53毫克氯前列醇钠(PGF),然后在第9天(取出P4植入物时)进行第二次PGF处理,以及肌肉注射1毫克环丙孕酮。然后,在所有实验组的第11天(取出P4后48小时)进行TAI。我们在第30天检测到处理对每次人工授精的妊娠率(P/AI)有影响,其中EBd0 - GnRHd2组的奶牛生育力高于EBd0组的奶牛,而EBd0 - GnRHd0组的奶牛与EBd0组和EBd0 - GnRHd0组之间没有差异(分别为40.5%、30.4%和34.4%)。总之,在基于雌二醇和P4的TAI方案开始时进行GnRH处理,只有在第2天给予GnRH时才能提高生育力。此外,在特定类别的奶牛中观察到了这种策略更明显的积极效果:经产奶牛、产奶量较高的奶牛以及接受首次输精的奶牛。